Poland
# |
Name |
Dividend Yield |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
0.00% |
Feb. 3, 2025 | USD 1.79 | -1.96% |
|
Poland |
|
2 |
0.00% |
Feb. 3, 2025 | USD 6.53 | 2.36% |
|
Poland |
|
3 |
0.00% |
Feb. 3, 2025 | USD 10.51 | -3.97% |
|
Poland |
|
4 |
0.00% |
Feb. 3, 2025 | USD 12.20 | -4.46% |
|
Poland |
|
5 |
0.00% |
Feb. 3, 2025 | USD 9.53 | 2.20% |
|
Poland |
|
6 |
0.00% |
Feb. 3, 2025 | USD 2.23 | -2.90% |
|
Poland |
The Clinical Trials company in Poland with the highest Dividend Yield is Medinice S.A. (Warsaw Stock Exchange: ICE.WA) at 0.00%.
The Clinical Trials company in Poland with the lowest Dividend Yield is Molecure S.A. (Warsaw Stock Exchange: MOC.WA) at 0.00%.
The top 10 Clinical Trials companies in Poland by Dividend Yield are Medinice S.A., Ryvu Therapeutics S.A., Selvita S.A., Captor Therapeutics Spolka Akcyjna, Poltreg S.A. and Molecure S.A..
The bottom 10 Clinical Trials companies in Poland by Dividend Yield are Molecure S.A., Poltreg S.A., Captor Therapeutics Spolka Akcyjna, Selvita S.A., Ryvu Therapeutics S.A. and Medinice S.A..